Nielsen BioSciences

CA - San DiegoDiagnostics2 H-1B visas (FY2023)

Focus: Nielsen BioSciences is a San Diego-based diagnostics and biologics company operating in the diagnostics segment. Limited public data constrains clarity on market position and scale.

Oncology Gastroenterology Neurology Nephrology

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Open Jobs

About Nielsen BioSciences

AI assessmentNot Hiring

No open roles listed right now. Follow Nielsen BioSciences to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Mid-stage

2 Phase 3+

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Bypass PACU in Knee and Hip Arthroplasty

Surgery

N/A

Clinical Trials (1)

NCT03984942Bypass PACU in Knee and Hip Arthroplasty

N/A

Help build intelligence for Nielsen BioSciences

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

San Diego headquarters offers access to a strong life sciences ecosystem with competitive talent networks and collaboration opportunities
Diagnostics focus in biologics represents a growing market segment with lower regulatory barriers than drug development
Early-stage company positioning offers potential equity upside and hands-on responsibility for those who join during formative growth phase

Watch Out For

Zero active job openings and minimal public profile suggest very limited hiring and possible dormancy or pivot phase
No disclosed pipeline, products, revenue, or financial data creates high uncertainty about company viability and career trajectory
Only 2 H-1B approvals in 2023 with no recent funding details visible suggests constrained resources and talent acquisition capacity

Generated by Claude from Nielsen BioSciences's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

PROSA: Prolactin, Sex Hormones, Growth and Metabolic Biomarkers in Children and Adolescents on Antip

Hyperprolactinemia

N/A

Clinical Trials (1)

NCT05033119PROSA: Prolactin, Sex Hormones, Growth and Metabolic Biomarkers in Children and Adolescents on Antipsychotics

N/A

Target temperature 36°C

Out-of-hospital Cardiac Arrest

N/A

Clinical Trials (1)

NCT01020916Target Temperature Management After Cardiac Arrest

N/A

Herpesvirus Immunology in Solid Organ Transplant Recipients - Liver Transplant Study

Cytomegalovirus Infections

N/A

Clinical Trials (1)

NCT05532540Herpesvirus Immunology in Solid Organ Transplant Recipients - Liver Transplant Study

N/A

CO-OP intervention

Stroke

N/A

Clinical Trials (1)

NCT06919315Effectiveness of the Cognitive Orientation to Daily Occupational Performance (CO-OP)

N/A

Text messaging

Hazardous Alcohol Use

N/A

Clinical Trials (1)

NCT06319885Text Messaging to Reduce High-risk Alcohol Use Among Older Adults

N/A

basic intervention

Cross-Sectional Study

N/A

Clinical Trials (1)

NCT03079375The Pharmacist Follows You and Your Medication From Hospital to Your Daily Life and Investigate What This Means to You

N/A

No intervention.

HIV

N/A

Clinical Trials (1)

NCT02382822Copenhagen Comorbidity in HIV Infection Study

N/A

Cerebral Palsy & Predictors of Physical Activity

Cerebral Palsy

N/A

Clinical Trials (1)

NCT04614207Cerebral Palsy & Predictors of Physical Activity

N/A

CBT-I

Treatment-refractory Schizophrenia

N/A

Clinical Trials (1)

NCT06749444Cognitive Behavioral Therapy for Sleep and Circadian Disturbances (CBT-I) in Treatment-Resistant Schizophrenia

N/A

Local infiltration analgesia

Pain, Postoperative

N/A

Clinical Trials (1)

NCT01362075Pain Management After Shoulder Prosthesis: A Clinical Trial of Nerve Block and Local Infiltration

N/A

Hyperbaric Oxygen

Pain

N/A

Clinical Trials (1)

NCT02025686Hyperbaric Oxygen Therapy Attenuates Central Sensitization Induced by a Thermal Injury in Human Volunteers (HBO)

N/A

Characteristics of the Anosmic Olfactory Mucosa

Anosmia

N/A

Clinical Trials (1)

NCT05562050Characteristics of the Anosmic Olfactory Mucosa

N/A

Meditation and mindfulness

Recurrent Pregnancy Loss

N/A

Clinical Trials (1)

NCT03905395Meditation and Mindfulness for Recurrent Pregnancy Loss

N/A

ATTACH

Mentalization

N/A

Clinical Trials (1)

NCT07162493ATTACH in Denmark: A Feasibility Randomized Controlled Trial

N/A

Brain imaging

Alcohol Use Disorder

N/A

Clinical Trials (1)

NCT06866379Involvement of the Septal Nuclei of the Human Brain in Alcohol Use Disorder

N/A

Sevoflurane-remifentanil anaesthesia

Nausea

N/A

Clinical Trials (1)

NCT00452855Sevoflurane-Remifentanil Anaesthesia. The Risk of Post Operative Nausea

N/A

Glycosaminoglycan Scores as Monitoring Biomarkers in Advanced Renal Cell Carcinoma

Carcinoma, Renal Cell

N/A

Clinical Trials (1)

NCT02732665Glycosaminoglycan Scores as Monitoring Biomarkers in Advanced Renal Cell Carcinoma

N/A

Perindopril

Hematoma, Subdural, Chronic

N/A

Clinical Trials (1)

NCT00915928Chronic Subdural Hematoma - Reduction of Recurrence by Treatment With Angiotensin Converting Enzyme Inhibitors

N/A

No intervention - pure observational study

Neuromuscular Diseases

N/A

Clinical Trials (1)

NCT052066173 Year Follow up on ANO5 Patients

N/A

Herpes Virus Infections in Kidney Transplant Patients

Kidney Transplant; Complications

N/A

Clinical Trials (1)

NCT05604911Herpes Virus Infections in Kidney Transplant Patients

N/A

Simulation-based learning

Endoscopy

N/A

Clinical Trials (1)

NCT04247399Simulation-assisted Teaching in Learning Gastroscopy

N/A

Removal or leaving of LAA occluders

Left Atrial Appendage Occluder

N/A

Clinical Trials (1)

NCT05014477Therapy Strategies After LAA Occluder Device Embolization

N/A

Free glycosaminoglycan profiling

Bladder Cancer

N/A

Clinical Trials (1)

NCT05799456Glycosaminoglycan Scores as Early Detection Biomarkers in Bladder Urothelial Carcinoma

N/A

HB-2121

Celiac Disease

Phase 1

Clinical Trials (1)

NCT07063823A First-in-human Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease

Phase 1

Irinotecan

Metastatic Colorectal Cancer

Phase 1

Clinical Trials (1)

NCT03295084Safety, Tolerability and Pharmacokinetics of Oral Tablet of Irinotecan in Adult Patients With Solid Tumors

Phase 1

PTG-100

Celiac Disease

Phase 1

Clinical Trials (1)

NCT04524221PTG-100 for Patients With Celiac Disease

Phase 1

HB-2121

Celiac Disease

Phase 1

Clinical Trials (1)

NCT07377565A First-in-Patient Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease

Phase 1

Radiolabeled [68Ga]ABY-025

HER2-positive Breast Cancer

Phase 1

Clinical Trials (1)

NCT02095210HER2 PET Imaging in Breast Cancer Patients Using [68GA]ABY-025

Phase 1

Acupuncture

Acupuncture Analgesia

Phase 1/2

Clinical Trials (1)

NCT00261755Acupuncture as Pain Relief and Relaxation During Childbirth

Phase 1/2

CANDIN

Warts

Phase 2

Clinical Trials (1)

NCT02393417Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)

Phase 2

Candida albicans Skin Test Antigen

Warts

Phase 2

Clinical Trials (1)

NCT01757392Candin Safety & Efficacy Study for the Treatment of Warts

Phase 2

oxaliplatin, capecitabine, trastuzumab

Metastatic Breast Cancer

Phase 2

Clinical Trials (1)

NCT01387373Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From Breast Cancer

Phase 2

Oxaliplatin, capecitabine, gemcitabine, cetuximab

Cholangiocarcinoma

Phase 2

Clinical Trials (1)

NCT01247337Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From Cholangiocarcinoma

Phase 2

Oxaliplatin

Metastatic Colorectal Cancer

Phase 2

Clinical Trials (1)

NCT04430985FOLFOX + Immunotherapy With Intrahepatic Oxaliplatin for Patients With Metastatic Colorectal Cancer

Phase 2

oxaliplatin, capecitabine, trastuzumab

Metastatic Breast Cancer

Phase 2

Clinical Trials (1)

NCT01387295Intra-hepatic Chemotherapy in Patients With Liver Metastases From Breast Cancer and Limited Extrahepatic Disease

Phase 2

Leishmania tropica Skin Test Antigen

Cutaneous Leishmaniasis

Phase 2

Clinical Trials (1)

NCT00633009Safety, False-Positive Reactions and Sensitizing Properties of Leishmania Tropica Skin Test Antigen

Phase 2

Pivmecillinam

Kidney Transplant Infection

Phase 2

Clinical Trials (1)

NCT07407673Prediction and Prevention of Bloodstream Infections After Kidney Transplantation

Phase 2

Candin, Intradermal Solution

Common Warts (Verruca Vulgaris)

Phase 3

Clinical Trials (1)

NCT05889845Candin for the Treatment of Common Warts

Phase 3

Spherule-derived coccidioidin

Coccidioidomycosis

Phase 3

Clinical Trials (1)

NCT00690092A Multi-center Study of Spherule-Derived Coccidioidin

Phase 3

estradiol

Turner Syndrome

Phase 4

Early transition to oral antibiotics

Brain Abscess

Phase 4

Clinical Trials (1)

NCT04140903Partial Oral Antibiotic Treatment for Bacterial Brain Abscess

Phase 4

Vitamin D3

Seasonal Affective Disorder

Phase 4

Clinical Trials (1)

NCT01462058The Role of Vitamin D Supplementation on Well Being and Symptoms of Depression During the Winter Season in Health Service Staff

Phase 4

Dexamethasone

Shoulder Impingement Syndrome

Phase 4

Clinical Trials (1)

NCT01414569Dexamethasone for Pain After Shoulder Surgery

Phase 4

Clozapine

Schizophrenia

Phase 4

Clinical Trials (1)

NCT05316883Biomarkers in Clozapine-responding Schizophrenia

Phase 4

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Portfolio: 44 clinical trials

Top TAs: Oncology, Gastroenterology, Neurology

H-1B (2023): 2 approvals

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Therapeutic Area Focus

8 pipeline

6 pipeline

3 pipeline

2 pipeline

2 pipeline

1 pipeline

Marketed

Pipeline

Visa Sponsorship

Sponsors Work Visas

H-1B Petitions (FY2023)

Approved

Denied

100%

Rate

Source: USCIS H-1B Employer Data Hub

Private Funding (SEC Form D)

Sep 2016